Patents by Inventor Alex BELSER

Alex BELSER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC PHENETHYLAMINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20250236589
    Abstract: There are disclosed phenethylamine compounds, the use of such compounds in the treatment of diseases associated with a serotonin 5-HT2 receptor, pharmaceutical compositions such as tablet compositions and kits containing the compounds, methods of delivering the compounds in a mist via inhalation, and methods of treating diseases or disorders associated with a serotonin 5-HT2 receptor, such as central nervous system (CNS) disorders or psychological disorders with the disclosed compounds.
    Type: Application
    Filed: February 15, 2023
    Publication date: July 24, 2025
    Applicant: Cybin IRL Limited
    Inventors: Alex Nivorozhkin, Joshua A. Hartsel, Clinton E. Canal, Francesco G. Salituro, Tina A. Mueller, Brett J. Greene, Alex Belser, Kenneth L. Avery, Amy Claire Reichelt, Geoffrey B. Varty, Michael Palfreyman
  • PHENETHYLAMINE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE
    Publication number: 20250145566
    Abstract: There are disclosed psychedelic and entactogen compounds, the use of such compounds in the treatment of diseases associated with a serotonin receptor or monoamine transporter, pharmaceutical compositions such as tablet compositions and kits containing the compounds, methods of delivering the compounds in a mist via inhalation, and methods of treating diseases or disorders associated with a serotonin receptor or monoamine transporter, such as inflammation, central nervous system (CNS) disorders or psychological disorders with the compounds of the invention.
    Type: Application
    Filed: February 15, 2023
    Publication date: May 8, 2025
    Applicant: Cybin IRL Limited
    Inventors: Alex Nivorozhkin, Joshua A. Hartsel, Clinton E. Canal, Francesco G. Salituro, Tina A. Mueller, Brett J. Greene, Alex Belser, Kenneth L. Avery, Amy Claire Reichelt, Geoffrey B. Varty, Michael Palfreyman
  • THERAPEUTIC PHENETHYLAMINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20240425451
    Abstract: There are disclosed deuterated 2C—X phenethylamine compounds. the use of such compounds in the treatment of diseases associated with a serotonin 5-HIT2 receptor, pharmaceutical compositions such as tablet compositions and kits containing the compounds. methods of delivering the compounds in a mist via inhalation, and methods of treating diseases or disorders associated with a serotonin 5-HT2 receptor, such as central nervous system (CNS) disorders or psychological disorders with the compounds of the invention.
    Type: Application
    Filed: September 5, 2024
    Publication date: December 26, 2024
    Applicant: Cybin IRL Limited
    Inventors: Alex Belser, Clinton E. Canal, Brett J. Greene, Joshua A. Hartsel, Alex Nivorozhkin, Michael Palfreyman
  • Therapeutic phenethylamine compositions and methods of use
    Patent number: 12122741
    Abstract: There are disclosed deuterated 2C—X phenethylamine compounds, the use of such compounds in the treatment of diseases associated with a serotonin 5-HT2 receptor, pharmaceutical compositions such as tablet compositions and kits containing the compounds, methods of delivering the compounds in a mist via inhalation, and methods of treating diseases or disorders associated with a serotonin 5-HT2 receptor, such as central nervous system (CNS) disorders or psychological disorders with the compounds of the invention.
    Type: Grant
    Filed: August 18, 2021
    Date of Patent: October 22, 2024
    Assignee: Cybin IRL Limited
    Inventors: Alex Belser, Clinton E. Canal, Brett J. Greene, Joshua A. Hartsel, Alex Nivorozhkin, Michael Palfreyman
  • PHENETHYLAMINE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE
    Publication number: 20240317704
    Abstract: There are disclosed psychedelic and entactogen compounds, the use of such compounds in the treatment of diseases associated with a serotonin 5-HT2 receptor, pharmaceutical compositions such as tablet compositions and kits containing the compounds, methods of delivering the compounds in a mist via inhalation, and methods of treating diseases or disorders associated with a serotonin 5-HT2 receptor, such as central nervous system (CNS) disorders or psychological disorders with the compounds of the invention.
    Type: Application
    Filed: August 18, 2021
    Publication date: September 26, 2024
    Applicant: CYBIN IRL LIMITED
    Inventors: Alex BELSER, Clinton E. CANAL, Brett J. GREENE, Joshua A. HARTSEL, Alex NIVOROZHKIN, Michael PALFREYMAN, Francesco SALITURO
  • THERAPEUTIC PHENETHYLAMINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20230312464
    Abstract: There are disclosed deuterated 2C—X phenethylamine compounds, the use of such compounds in the treatment of diseases associated with a serotonin 5-HT2 receptor, pharmaceutical compositions such as tablet compositions and kits containing the compounds, methods of delivering the compounds in a mist via inhalation, and methods of treating diseases or disorders associated with a serotonin 5-HT2 receptor, such as central nervous system (CNS) disorders or psychological disorders with the compounds of the invention.
    Type: Application
    Filed: August 18, 2021
    Publication date: October 5, 2023
    Applicant: CYBIN IRL LIMITED
    Inventors: Alex BELSER, Clinton E. CANAL, Brett J. GREENE, Joshua A. HARTSEL, Alex NIVOROZHKIN, Michael PALFREYMAN